Du Qiang Wang

Direttore/Membro del Consiglio presso NOVOPROTEIN SCIENTIFIC INC.

39 anni

Retail Trade

Consumer Services

Commercial Services

Profilo

Du Qiang Wang is currently the Director at Novoprotein Scientific (Shanghai), Inc. since 2020.
He is also the Board Secretary, Director & Deputy General Manager at Suzhou Novoprotein Scientific Co., Ltd.
since 2010.
Mr. Wang graduated from Fudan University in 2017.

Posizioni attive di Du Qiang Wang

Società	Posizione	Inizio
NOVOPROTEIN SCIENTIFIC INC.	Direttore/Membro del Consiglio	15/04/2021
Novoprotein Scientific (Shanghai), Inc. Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu.	Direttore/Membro del Consiglio	12/08/2020

Tutte le posizioni attive di Du Qiang Wang

Formazione di Du Qiang Wang

Fudan University

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Du Qiang Wang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
NOVOPROTEIN SCIENTIFIC INC.	Commercial Services

Aziende private	1
Novoprotein Scientific (Shanghai), Inc. Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu.	Retail Trade